ESC Premium Access

Late Breaking Trials - COVID-19

Event: ESC Congress 2021 - The Digital Experience
Topic: Other
Session type: Late-Breaking Science
Date: 29 August 2021
Time: 08:00 - 08:45

Congress Session

Become an ESC member to access this resource

Become a member

Already a member? Sign in

4 presentations in this session

Colchicine in Patients Hospitalized with COVID-19

Speaker: Doctor R. Diaz (Rosario, AR)
Thumbnail

The Michelle trial: Medically Ill hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis with rivaroxaban ThErapy

Speaker: Doctor E. Ramacciotti (Santo Andre, BR)
Thumbnail

Insights into the Effects of the COVID-19 Pandemic: Comprehensive Analysis from the GUIDE-HF Trial

Speaker: Doctor M. Zile (Charleston, S C, US)
Thumbnail

PREPARE-IT: Icosapent Ethyl Versus Placebo in People Exposed to COVID-19

Speaker: Doctor R. Diaz (Rosario, AR)
Thumbnail

4 speakers from this session

Doctor Rafael Diaz

Estudios Cardiologicos Latinoamerica (ECLA), Rosario (Argentina)
2 presentations
0 follower

Doctor Eduardo Ramacciotti

Science Valley Research Institute, Santo Andre (Brazil)
2 presentations
0 follower

Doctor Michael Zile

Medical University of South Carolina & VA Med Ctr, Charleston, S C (United States of America)
3 presentations
0 follower

Doctor Rafael Diaz

Estudios Cardiologicos Latinoamerica (ECLA), Rosario (Argentina)
2 presentations
0 follower

Related content

ESC Premium Access

Trials Focus: SSaSS / FIGARO-DKD

3 December 2021

ESC Premium Access

Current controversies in antithrombotic therapy

3 December 2021

ESC Premium Access

Opening session

2 December 2021

This platform is supported by

logo Novo Nordisk